Related Experiment Video
Updated: Oct 1, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Warfarin usage in Alaska: a quality improvement study
Abstract:
This study represents a snapshot view of a possible area for quality improvement work. We realize that a variety of events may have contributed to the deaths that occurred in our study cohort. In addition, the small number of cases reviewed precludes the formulation of conclusive statements regarding warfarin use in Alaska. Nevertheless, we are reporting the results in the hope of raising awareness in the Alaska medical community about the use of warfarin in treating atrial fibrillation and the benefits this therapy may have for the elderly patient.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease IV: Nursing Management